Gelfand Scott
Camb Q Healthc Ethics. 2020 Apr;29(2):223-235. doi: 10.1017/S0963180119001026.
The nocebo effect, a phenomenon whereby learning about the possible side effects of a medical treatment increases the likelihood that one will suffer these side effects, continues to challenge physicians and ethicists. If a physician fully informs her patient as to the potential side effects of a medicine that may produce nocebogenic effects, which is usually conceived of as being a requirement associated with the duty to respect autonomy, she risks increasing the likelihood that her patient will experience these side effects and therefore suffer (unnecessary) harm, a violation of the duty of nonmaleficence. If, on the other hand, she intentionally withholds side effect information in an effort to protect her patient from suffering unnecessary harm from side effects, which is consistent with the duty of nonmaleficence, she violates the duty to respect patient autonomy. In this paper, the author discusses several previous attempts to deal with the nocebo effect and explains their weaknesses. He then proposes a means of managing the nocebo effect and argues that it does not share the weaknesses found in previous approaches. He concludes with a discussion of a simple, yet practical tool that might help clinicians manage the tension resulting from the nocebo effect.
反安慰剂效应是一种现象,即了解某种医学治疗可能产生的副作用会增加出现这些副作用的可能性,这一现象持续困扰着医生和伦理学家。如果医生向患者充分告知某种可能产生反安慰剂效应的药物的潜在副作用,而这通常被视为尊重患者自主权这一职责相关的要求,那么她就有可能增加患者出现这些副作用并因此遭受(不必要)伤害的可能性,这违反了不伤害的职责。另一方面,如果她为了保护患者免受副作用带来的不必要伤害而故意隐瞒副作用信息,这与不伤害的职责相符,但她却违反了尊重患者自主权的职责。在本文中,作者讨论了此前应对反安慰剂效应的几种尝试,并解释了它们的不足之处。然后,他提出了一种应对反安慰剂效应的方法,并认为该方法不存在此前方法中的弱点。他最后讨论了一种简单却实用的工具,该工具可能有助于临床医生应对反安慰剂效应所导致的紧张局面。